IP Library › Assignment 020617/0673
Patent Assignment
Reel/Frame 020617/0673

Change of Assignee Address

Recorded: 2008-03-10 Pages: 6
Assignor
OXIGENE, INC.
Executed: 2003-01-23
Assignee
OXIGENE, INC.
230 THIRD AVENUE, WALTHAM, MASSACHUSETTS, 02451
Covered Property (1)
Functionalized Stilbene Derivatives as Improved Vascular Targeting Agents
Patent: 6,919,324 →
Application: 10/281,528 →
Publication: US 2003/0149003
Related Assignments (4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Jan 23, 2003
From: CHAPLIN, DAVID J.; PREZIOSO, JOSEPH ANTHONY; EDVARDSEN, KLAUS
To: OXIGENE, INC.
Reel/Frame 013692/0021 →
Assignment of Assignor's Interest May 11, 2004
From: GARNER, CHARLES M., III; KANE, ROBERT R.; PINNEY, KEVIN G.
To: BAYLOR UNIVERSITY
Reel/Frame 015314/0848 →
Corrective Assignment to Correct the Execution Date for Klaus Edvardsen Previously Recorded at Reel: 013692 Frame: 0021. Assignor(S) Hereby Confirms the Assignment . Jun 29, 2016
From: CHAPLIN, DAVID J.; PREZIOSO, JOSEPH ANTHONY; EDVARDSEN, KLAUS
To: OXIGENE, INC.
Reel/Frame 039207/0404 →
Change of Name Jul 26, 2016
From: OXIGENE, INC.
To: MATEON THERAPEUTICS, INC.
Reel/Frame 039264/0377 →